Cargando…

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment

Most testosterone (T) replacement therapy (TRT) products have relied on dose titration to achieve eugonadal levels. However, dose titration in clinical practice can be time-consuming, expensive, and subject to errors. TLANDO (LPCN 1021) is a novel oral testosterone undecanoate (TU) product absorbed...

Descripción completa

Detalles Bibliográficos
Autores principales:	DelConte, Anthony, Patel, Mahesh V, Papangkorn, Kongnara, Chidambaram, Nachiappan, Bruno, Benjamin J, Kim, Kilyoung, Frank, Joel, Khera, Mohit, Miner, Martin, Kaminetsky, Jed, Vignozzi, Linda, Goldstein, Irwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208873/ http://dx.doi.org/10.1210/jendso/bvaa046.684

Ejemplares similares

A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
por: DelConte, Anthony, et al.
Publicado: (2022)

SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020)

TLANDO, a Novel Oral TRT, Improves Sexual and Mental Domain Outcomes in Hypogonadal Men
por: Bruno, Benjamin J, et al.
Publicado: (2021)

Efficacy and Safety of TLANDO, A Novel Oral Easy to Prescribe and Use TRT Option
por: Papangkorn, Kongnara, et al.
Publicado: (2021)

Low Testosterone in Males May Warrant Liver Health Assessment and Intervention
por: DelConte, Anthony, et al.
Publicado: (2021)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

037 Is Oral Testosterone a Potential Treatment for COVID-19 in Men?
por: Papangkorn, K., et al.
Publicado: (2021)

SAT-045 Free Testosterone and Cardiometabolic Parameters in Adult Men - Comparison of Algorithms for Calculation of Serum Free Testosterone
por: Holmboe, Stine Agergaard, et al.
Publicado: (2020)

SAT-047 Adoption of an Age Adjusted Testosterone Reference Range Reduces Referrals to Endocrine Clinic and New Prescriptions of Testosterone
por: Dewdney, Charlotte, et al.
Publicado: (2020)

Ceiling effect of clomiphene citrate on the testosterone to estradiol ratio in eugonadal infertile men
por: Liao, Yian, et al.
Publicado: (2022)

SAT367 A Rare Case of Ovarian Cellular Fibroma Producing Testosterone
por: Rai, Harpreet Kaur, et al.
Publicado: (2023)

SAT-LB2 Elevated Testosterone Secondary to Leydig Cell Hyperplasia in Bilateral Ovaries
por: Ali, Sarah, et al.
Publicado: (2020)

SAT-LB6 First Human Trial of an Oral Native Testosterone Shows Physiological Levels of Testosterone and Dht in Both Fasted and Fed State in Hypogonadal Men
por: Newell-Price, John D C, et al.
Publicado: (2020)

SAT-041 Testosterone Reduces Atherosclerosis and Plaque Specific Inflammatory Markers in the ApoE-/- Mouse Model
por: Bateman, Lauren, et al.
Publicado: (2020)

SAT-LB8 The Testosterone-To-Estradiol Ratio, Rather Than Testosterone or Estradiol Alone, Is a More Precise Marker of Metabolic-Related Outcomes in Males: Insights From a Systematic Review
por: Cadegiani, Flavio, et al.
Publicado: (2020)

SAT-LB043 Elevated Testosterone Exposure Affects Ciliary Function and Gene Expression in the Human Fallopian Tube
por: Jackson-Bey, Tia, et al.
Publicado: (2019)

SUN-229 The Role of Testosterone in Spermatogenesis: Lessons from Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
por: Grande, Giuseppe, et al.
Publicado: (2019)

THU645 Comparison Of LC-MS/MS Testosterone Assays Towards Standardization Of Lower Testosterone Ranges
por: Cree, Melanie G, et al.
Publicado: (2023)

Controversies in testosterone supplementation therapy
por: Khera, Mohit
Publicado: (2015)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

SAT-033 U-Shaped Association of Plasma Testosterone, and No Association of Plasma Estradiol, with Incidence of Any Fracture and Hip Fracture in Older Men
por: Yeap, Bu Beng, et al.
Publicado: (2020)

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

Testosterone’s Role in COVID-19
por: Auerbach, Jeremy M., et al.
Publicado: (2021)

SAT-LB004 Therapeutic Potential of LPCN 1144 in NAFLD and NASH
por: Baker, Jonathan, et al.
Publicado: (2019)

SAT-050 Low Serum Testosterone (T) Is Associated with Poor Health Status in Young to Middle-Aged Human Immunodeficiency Virus (HIV)-Infected Men
por: Vincentis, Sara De, et al.
Publicado: (2020)

AB173. Effect of testosterone replacement therapy on lipid profile in the patients with testosterone deficiency syndrome
por: Han, Kyung-Sik, et al.
Publicado: (2014)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

SUN-217 Alternate Pathways of Testosterone Action in Testis
por: Talapatra, Arpita
Publicado: (2019)

FRI428 VTE And Testosterone Therapy: What Is The Risk?
por: Cheatham, Callie, et al.
Publicado: (2023)

FRI431 Erythrocytosis Associated With Oral Testosterone Replacement
por: Engel, Ashley A, et al.
Publicado: (2023)

SAT-049 Testosterone Therapy Reduces Inflammatory Activation of Human Monocytes in Hypogonadal Type-2 Diabetic Men as a Potential Mechanism to Improve Atherosclerosis
por: Bateman, Lauren, et al.
Publicado: (2020)

MON-LB002 Compounded Testosterone Preparations Raise Testosterone Levels to Premenopausal Ranges in Postmenopausal Women With Hypo-Sexual Desire Disorder (HSDD)
por: Olson, Beatriz Rodriguez
Publicado: (2020)

SAT-030 The Barnsley Diabetes Hypogonadal Questionnaire (BDHQ) - Validation for the Clinical Use to Support the Diagnosis of Testosterone Deficiency in Men with Type 2 Diabetes (T2D)
por: Mumdzic, Enis, et al.
Publicado: (2020)

SUN-206 Acute Cardiovascular Complications FromTestosterone Therapy
por: Shakir, Mohamed, et al.
Publicado: (2019)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

MON-206 Analysis of Concomitant AMH and Testosterone Results in 3213 Female Samples: Contrary to Common Belief, AMH and Testosterone Levels Are Not Elevated in Tandem in Most Women
por: Chandler, Donald, et al.
Publicado: (2019)

SUN-227 Monitoring Testosterone (T) Levels in Men Receiving Oral Testosterone Undecanoate (TU): Challenges Due to Post-Collection Conversion of TU-to-T and a Path Forward
por: Swerdloff, Ronald, et al.
Publicado: (2019)

Use of a Lab-Ordering Pathway to Improve Adherence to Endocrine Society (ES) Guidelines for Early AM Timing and Testosterone Assay Method for Establishing Testosterone Deficiency
por: Gammoh, Emily, et al.
Publicado: (2021)

SAT-044 Treatment of Hypogonadal Men with a New Oral Testosterone Undecanoate (TU) Formulation Improves Psychosexual, Well-Being and Body Composition and Bone Density Parameters
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bp7sa13d75it24uk8fkmhg7897